Gynecological Line:

Clinical Line:

Pediatric Line:

Products

Gynecological Line

Dipni® Vaginal – Oral Tablets

Unique due to its fast vaginal disintegration

Treatment of albicans and non-albicans candidiasis

separar

Perfect for pregnant and/ or immuno-compromised patients

separar

Patient information

Formula:
Formula:
-Dipni vaginal tablets:
Each tablet contains Nystatin 100.000U.I.
-Dipni oral tablets:
Each oral tablet contains Nystatin 500.000 UI.


Therapeutical Action :
Therapeutical action:
Antimycotic, fungistatic and polyenic derivative fungicide.


Indications:
Indications:
-Dipni vaginal tablets:
Local treatment of mycotic vulvovaginitis.
-Dipni oral tablets:
Orofaryngeal Candidiasis and mycotic processes involving intestinal Candida.
Contraindications: Hypersensibility to Nystatin or other polyenic derivatives.


Posology:
Posology:
-Dipni vaginal tablets:
Acute Candidiasis: 1 to 2 vaginal tablets per days for 6 to 12 days.
Recurrent Candidiasis: 1 vaginal tablet for 2 weeks, followed by 1 vaginal tablet 2 nights per week during 3, 6, or 12 months.
-Dipni oral tablets:
Usual dose by oral way is of 1 to 2 tablets four times per day up to 14 days.


Presentation:
Presentation:
-Dipni vaginal tablets:
Packages containing 6 and 12 vaginal tablets.
-Dipni oral tablets:
Packages containing 12 and 30 oral tablets.